Abstract
The crucial role of T cells in atherosclerosis and coronary artery disease (CAD) has been highlighted by recent observations. Helper CD4(+) T cells can both aggravate or attenuate the atherogenic process and the development of CAD. CD4(+)CD28(null) T cells are an unusual subset of helper cells which expand and have deleterious effects in CAD. In this review, we discuss the current issues on the generation of CD4(+)CD28(null) T cells and focus on their phenotypic and functional characteristics relevant to the development of cardiovascular events. The possible effects of the present day therapies for CAD on the CD4(+)CD28(null) T cells are also explored. Targeting the CD4(+)CD28(null) T cell subset in CAD could provide novel therapeutic strategies to prevent acute life-threatening coronary events.
| Original language | English |
|---|---|
| Pages (from-to) | 11-9 |
| Number of pages | 9 |
| Journal | Cardiovascular Research |
| Volume | 81 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2009 |
Keywords
- Animals
- Autoimmune Diseases/pathology
- CD28 Antigens/genetics
- Coronary Artery Disease/drug therapy
- Coronary Vessels/pathology
- Disease Models, Animal
- Humans
- T-Lymphocytes, Helper-Inducer/immunology
- Thrombosis/pathology